Wagner, Alignment healthcare CHRO, sells $393k in stock
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Iran conflict latest: Hegseth says Iran conflict has "only just begun" Gold hands back gains as US dollar rebounds; Middle East war continues Morgan Stanley explains why gold is falling despite Iran escalation Nasdaq ends more than 1% higher as solid economic data lifts spirits (South Africa Philippines Nigeria) Wagner, Alignment healthcare CHRO, sells $393k in stock By Insider Trading Published 03/05/2026, 03:16 AM Wagner, Alignment healthcare CHRO, sells $393k in stock 0 ALHC 2.33% Alignment Healthcare (NASDAQ:ALHC) Chief Human Resources Officer Andreas P. Wagner sold 21,118 shares of common stock on March 4, 2026, for approximately $393,250. The sales were executed at a weighted-average price of $18.6216, with individual sales prices ranging from $18.47 to $18.89. The stock currently trades at $18.88 with a market cap of $3.86 billion. Following the transaction, Wagner directly owns 148,687 shares of Alignment Healthcare. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2025.The insider sale comes as the stock has declined 7.5% over the past week. According to InvestingPro analysis, ALHC appears undervalued at current levels based on Fair Value metrics. For deeper insights, investors can access comprehensive Pro Research Reports covering ALHC and 1,400+ other US equities. In other recent news, Alignment Healthcare announced the pricing of a secondary offering of 13.2 million shares at $19.46 per share. This offering is led by an affiliate of General Atlantic, L.P., and the company clarified that it will not receive any proceeds from this sale. The offering is expected to close on March 4, 2026, subject to customary closing conditions, with J.P. Morgan serving as the underwriter. Additionally, the company reported strong fourth-quarter results, with membership growth of approximately 25% year-over-year and revenue growth of approximately 44.4%. The medical benefit ...
Read full article at source